// App-Quantinova.ai

1852 : Gvhd and Relapse Free Survival (GRFS) after Allogeneic Transplantation for Idiopathic Severe Aplastic Anemia: An Analysis from the Saawp Data Quality Initiative Program of EBMT

Researchers

Presenter

  • Raynier Devillier

Principal Investigators

  • Paul Bosman

  • Carlo Dufour

  • Mahmoud Aljurf

  • Depei Wu

  • Alexey Maschan

  • Boris V. Afanasyev

  • Constantijn Halkes

  • Matthew P. Collin

  • John A Snowden

  • Yves Bertrand

  • Arnold Ganser

  • Karl-Walter Sykora

  • Brenda Gibson

  • Johan Maertens

  • Maija Itl-Remes

  • Corti Paola

  • Jan J. Cornelissen

  • Martin Bornhuser

  • Mercedes Colorado Araujo

  • Hakan Ozdogu

  • Antonio Risitano

  • Regis Peffault De Latour

Medical Centers

  • Institut Paoli-Calmettes, Marseille, France

  • CRCM, INSERM U1068, Marseille, France

  • Aix Marseille University, Medicine Faculty, Marseille, France

  • EBMT Data Office Leiden, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands

  • EBMT Leyden Office, Leyden, The Netherlands,

  • Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation, Leiden, Netherlands

  • Hematology Unit, Istituto Giannina Gaslini, Genoa, Italy

  • King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia

  • First Affiliated Hosp of Soochow Univ, Suzhou Jiangsu, China

  • Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

  • RM Gorbacheva Research Institute, Pavlov University,St Petersburg,Russia

  • Department of Urology, Leiden Unviersity Medical Center, Leiden, Netherlands

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

  • Institute of Pediatric Hematology and Oncology, Civil Hospital of Lyon, Claude Bernard University, Lyon, France

  • Klinik fur Hamatologie, Hamostaseologie, Onkologie und Stammzelltransplantation, Medizinische Hochschule Hannover, Hannover, Germany

  • Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany

  • Department of Hematology, Royal Hospital for Children, Glasgow, GBR

  • University Hospital Gasthuisberg, Leuven, Belgium

  • Turku University Hospital, Stem cell transplantation unit, Turku, Finland

  • Oncologia Medica, Ospedale San Gerardo, Monza, Italy

  • Department of Hematology, Erasmus MC Cancer Insitute, Rotterdam, Netherlands

  • Department of Hematology and Oncology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany

  • Hospital U. Marqués de Valdecilla, Servicio de Hematología-Hemoterapia, Santander, Spain

  • Radiology, Baskent University, Ankara, Turkey

  • Department of clinical medicine and surgery, University of Naples Federico II, Naples, Italy

  • French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Assistance Publique – Hôpitaux de Paris, Université de Paris, Paris, France

  • Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation, Leiden, Netherlands

Locations

  • France

  • Netherlands

  • Italy

  • Saudi Arabia

  • China

  • Russia

  • United Kingdom

  • Germany

  • Belgium

  • Finland

  • Spain

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Aplastic anemia

  • Graft-versus-host disease

Biomarkers

  • Serum amyloid A

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved